CLINICAL_TRIALS
withdrawal
· 2026-01-21
Clinical Trial Update: Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT [EARLY_Phase 1]
Summary
An EARLY Phase 1 clinical trial investigating long-term potentiation disruption underlying cognitive impairment in electroconvulsive therapy has been withdrawn.…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of New Mexico | Conditions: Major Depressive Disorder, Bipolar Disorder II | EARLY_Phase 1 | Status: WITHDRAWN